Evidence map›Paper›PMID 38418241›Full record

ArticleBMJ open2024

Non-indicated vitamin B

Joris Ljm Müskens, Rudolf Bertijn Kool, Gert P Westert, Maarten Zaal, Hein Muller, Femke Atsma, S A van Dulmen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Joris Ljm MüskensIQ Health science department, Radboud University Medical Centre, Nijmegen, The Netherlands Joris.muskens@radboudumc.nl.ORCID 0000-0002-9440-7703
Rudolf Bertijn KoolIQ Health science department, Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0003-3134-487X
Gert P WestertIQ Health science department, Radboud University Medical Centre, Nijmegen, The Netherlands.
Maarten ZaalDutch Hospital Data, Utrecht, The Netherlands.
Hein MullerDutch Hospital Data, Utrecht, The Netherlands.
Femke AtsmaIQ Health science department, Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0002-5944-2431
S A van DulmenIQ Health science department, Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0003-4003-8540
Radboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the extent of non-indicated vitamin B

designCross-sectional study using registration data from 2015 to 2019.

participantsPatients aged between 18 and 70 years who received a vitamin B PRIMARY AND SECONDARY OUTCOME MEASURES: The proportion of non-indicated vitamin B

resultsBetween 2015 and 2019, at least 79.0% of all vitamin B

conclusionHospital clinicians order vitamin B

Indexed as

Vitamin B 12Vitamin B 12 DeficiencyAdolescentAdultAgedCross-Sectional StudiesHospitalsHumansMiddle AgedVitaminsYoung AdultVitamin B 12VitaminsClinical Decision-MakingHospitals, PublicQuality in health careRetrospective Studies

Identifiers

PMID38418241
PMCPMC10910490
OpenAlexW4392300789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.